[After-care of the patient with myocardial infarct].
Patients after myocardial infarction are at a substantial risk for recurrent cardiac events; therefore, an optimal patient care is of great importance. Early revascularisation is one important contributor to the prognosis after myocardial infarction. Antithrombotic agents, betablockers, and ACE-inhibitors also contribute significantly to the improved outcome after myocardial infarction. Reduction of risk factors, in particular cessation of smoking and lowering of lipids are of highest importance to improve the prognosis after myocardial infarction.
Muntwyler
J
J
Departement Innere Medizin, Universitätsspital Zürich.
Rickli
H
H
Kiowski
W
W
Amann
F W
FW
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000359:Aftercare; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D008019:Life Style; D009203:Myocardial Infarction / Q000534:rehabilitation*; D012008:Recurrence; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents